Compare Amylx Pharmaceuticals Inc (AMLX) vs Cloudflare Inc (NET) Price & Performance

Amylx Pharmaceuticals IncTrade

Cloudflare IncTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Cloudflare Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.53B), while Cloudflare Inc trades at $306.18 (market cap $110.59B). The key difference: Cloudflare Inc is far larger — about 43.7× Amylx Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.

	AMLX	NET
Market Cap	$2.53B	$110.59B
Sector	Health	Technology
52-Week High	$24.19	$310.40
52-Week Low	$7.82	$160.16
Enterprise Value	$2.28B	$109.96B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amylx Pharmaceuticals Inc

AMLX trades at $22.82, down 5.66% on the day, with a bullish technical signal from moving averages and key support at $22. The company reported a net loss of -$144.74M for 2025, with negative ROE and ROA, but holds a $250.8M cash runway into 2028. The pivotal Phase 3 LUCIDITY trial for avexitide is set for a late August/early September 2026 readout, a key near-term catalyst.

Analyst consensus is strongly bullish with a $30.00 price target, though recent earnings misses and negative cash flow from operations in 2026 pose risks. The stock's outlook hinges on successful clinical trial results and the subsequent regulatory pathway for its lead endocrine asset.

Cloudflare Inc

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AMLX

Amylyx shifts focus to endocrine drug avexitide with strong cash runway into 2028 and key trial results in 2026Seeking Alpha · 4 days agoBullish View details →

NET

OpenAI expands Daybreak cyber defense with new GPT-5.6-Cyber model for advanced security tasksTechCrunch · 1 day agoBullish Fastly shares jump 21% on strong Q2 results and raised full-year outlook, hitting highest levels since early 2024.24/7 Wall Street · 1 day agoBullish Software stocks swing as AI fears hit valuations; Atlassian and Twilio rally after earnings.CNBC · 4 days agoNeutral View details →

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

About Cloudflare Inc

Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.